Key facts
- AcuityMD’s last known valuation is $980.0M (Dec 2025).
- It has raised $173.7M across 1 recorded rounds; the latest was Early Stage VC ($31.0M) in Mar 2022.
- Notable investors include Redpoint Ventures, StepStone Group, ICONIQ Growth, Benchmark Capital, Artisanal Ventures — 10 tracked in total.
- AcuityMD has filed 1 Form D with the SEC, most recently May 2022 ($31.0M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for AcuityMD
Funding rounds
1 roundsAbout AcuityMD
Developer of commercial intelligence software designed for medical device companies to optimize sales strategy across the product lifecycle. The company's platform integrates external market data with internal sales information, delivering account insights, product adoption tracking, and performance analytics, enabling medical companies to prioritize opportunities and drive revenue growth.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2018
- Employees
- 188
- Website
- acuitymd.com/
- Ownership
- Privately Held (backing)
AcuityMD doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AcuityMD shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AcuityMD in its N-PORT filings yet. We sweep new filings monthly.